Nutanix jobs

Senior Staff Global Practice Lead – Cloud Native Senior Staff Global Practice Lead - Cloud Native

Enterprise Solution Architect (AI & Data Center Infrastructure) Enterprise Solution Architect (AI & Data Center Infrastructure)

Member of Technical Staff 3 [5-9 years]- Python Automation, Networking Member of Technical Staff 3 [5-9 years]- Python Automation, Networking

Advisory Enterprise Account Manager - NYC Advisory Enterprise Account Manager - NYC

Indirect Procurement Manager - Software Technology, Hardware and Professional Services Indirect Procurement Manager - Software Technology, Hardware and Professional Services

Resolution Manager - WW Support Resolution Manager - WW Support

Senior Director of CMC and Nonclinical Program Management North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix

Pharmacovigilance Scientist Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an experienced Pharmacovigilance Scientist

Senior Manager, Total Rewards Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Manager, Total Rewards

Senior Specialist, Regulatory Operations Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Specialist, Regulatory Operations, will

Scientist II, Animal Model Development Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix Research and Development Center

Business Development Manager – Hybrid Cloud & Datacenter Uusimaa, Finland Tehtävässä menestyminen edellyttää aikaisempaa kokemusta Hybrid Cloud -datakeskusratkaisuista, erityisesti Dell- ja Hypervisor-osaaminen (Nutanix ja/tai Broadcom) on tehtävässä eduksi. At TD SYNNEX, w...

Manager, Quality Systems & Administration North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview: The Manager, Quality Systems

Platform Operations Engineer Singapore The Platform Operations Engineer is responsible for maintaining and supporting on-premises infrastructure platforms that underpin mission-critical systems. This role ensures platform reliability, operational stability, and drives infrastructure modernisation and automation initiatives, while maintaining robust support for existing agency systems. The role also supports the agency's transition towards cloud adoption and hybrid infrastructure , including the migration and modernisation of existing workloads. You will collaborate closely with internal teams and vendors to ensure the stability, performance, and security of essential government IT infrastructure. Key Responsibilities - Maintain and support critical infrastructure platforms, including compute, storage, virtualisation, and supporting systems across development, staging, and production environments. - Implement platform standards, automation, and modern operational practices to improve efficiency and reliability. - Support infrastructure enhancement and modernisation initiatives in alignment with enterprise architecture standards. - Manage virtualisation platforms (e.g., VMware, Hyper-V, Nutanix), including capacity monitoring, performance optimisation, and lifecycle management. - Execute patching and upgrade strategies using automation while minimising service disruption. - Provide L2/L3 technical support, including incident management, root cause analysis, and problem resolution. - Maintain backup, disaster recovery (DR), and high-availability (HA) solutions. - Implement and enforce security controls, including access management, system hardening, and compliance monitoring. - Collaborate with application, network, and vendor teams to ensure platform stability, scalability, and service performance. - Develop and maintain documentation, runbooks, and standard operating procedures (SOPs). - Support and troubleshoot infrastructure and network-related issues to ensure end-to-end service availability. - Support cloud migration and hybrid infrastructure initiatives, including

Manager, Trade & Market Access Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager of Trade

Junior Frontend Engineer Hyderabad, India | OnSite ABOUT PLANE Plane is an incisive response to config-heavy, opinionated, and restrictive project management software. Check out our website https://plane.so/. In just two years, Plane's grown to #1 in its category on GitHub and become a viable open-core alternative to Jira, Monday, Wrike, Asana, ClickUp, and Linear, not to mention all-in-one tools like Notion or Obsidian. Our growth has come on the back of the product's true flexibility without artificial limits, simple configurations that work out of the box, and thoughtfully packaged features that nurture our customers' growth instead of punishing it. As a modern product start-up, we obsess over new and power users equally. Our mission is to empower teams everywhere with the simplest, most delightful work management experience on the planet. Our vision is to become the WorkOS of the future with a workbench of unified tools and techniques that intuitively and progressively form a greater whole for knowledge workers. We're well capitalized, backed by OSS Capital, and are revenue-positive. Our coworkers include ex-Microsoft, Deloitte, [24]7, Nutanix, and Yahoo! in our 50+ strong human force today. ABOUT THE ROLE We're looking for a Junior Frontend Engineer who is early in their career but already shows real hunger for the craft of building software. This is a role for someone who wants to work on a product that thousands of teams rely on, learn from engineers who care deeply about quality, and grow quickly by taking on meaningful, well-scoped problems. You won't

Senior Manager, Cost Accounting Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.

Node JS Developer (Backend) Hyderabad, India | OnSite ABOUT PLANE Plane is an incisive response to config-heavy, opinionated, and restrictive project management software. Check out our website https://plane.so/. In just two years, Plane's grown to #1 in its category on GitHub and become a viable open-core alternative to Jira, Monday, Wrike, Asana, ClickUp, and Linear, not to mention all-in-one tools like Notion or Obsidian. Our growth has come on the back of the product's true flexibility without artificial limits, simple configurations that work out of the box, and thoughtfully packaged features that nurture our customers' growth instead of punishing it. As a modern product start-up, we obsess over new and power users equally. Our mission is to empower teams everywhere with the simplest, most delightful work management experience on the planet. Our vision is to become the WorkOS of the future with a workbench of unified tools and techniques that intuitively and progressively form a greater whole for knowledge workers. We're well capitalized, backed by OSS Capital, and are revenue-positive. Our coworkers include ex-Microsoft, Deloitte, [24]7, Nutanix, and Yahoo! in our 50+ strong human force today. WHAT YOU WILL DO? • Work at the intersection of core plane application and external integrations like Slack, GitHub and AI. • Improve our importer, integration reliability to migrate data safely from tools like Jira, Linear etc. • Elevate our service's reliability with superior observability, monitoring, and alert systems, enabling prompt incident responses. • Expand our service's capabilities with strategic architectural and infrastructural upgrades.

Backend Engineer (Python/ Django) Hyderabad, India | OnSite ABOUT PLANE Plane is an incisive response to config-heavy, opinionated, and restrictive project management software. Check out our website https://plane.so/. In just two years, Plane's grown to #1 in its category on GitHub and become a viable open-core alternative to Jira, Monday, Wrike, Asana, ClickUp, and Linear, not to mention all-in-one tools like Notion or Obsidian. Our growth has come on the back of the product's true flexibility without artificial limits, simple configurations that work out of the box, and thoughtfully packaged features that nurture our customers' growth instead of punishing it. As a modern product start-up, we obsess over new and power users equally. Our mission is to empower teams everywhere with the simplest, most delightful work management experience on the planet. Our vision is to become the WorkOS of the future with a workbench of unified tools and techniques that intuitively and progressively form a greater whole for knowledge workers. We're well capitalized, backed by OSS Capital, and are revenue-positive. Our coworkers include ex-Microsoft, Deloitte, [24]7, Nutanix, and Yahoo! in our 50+ strong human force today. WHAT YOU WILL DO? - Develop the backbone for a variety of user-centric features. - Enhance the efficiency of real-time data synchronization across our platforms. - Boost database and system performance through advanced caching techniques and connection pooling. - Elevate our service's reliability with superior observability, monitoring, and alert systems, enabling prompt incident responses. - Expand our service's capabilities with strategic architectural and infrastructural

Sr Principal DevOps Engineer (26-204) United States-Colorado-Schriever AFB RELOCATION ASSISTANCE: No relocation assistance available CLEARANCE REQUIRED FOR START: Yes CLEARANCE TYPE: Top Secret TRAVEL: No Description At Northrop Grumman, our employees have incredible opportunities to work on revolutionary systems that impact people's lives around the world today, and for generations to come. Our pioneering and inventive spirit has enabled us to be at the forefront of many technological advancements in our nation's history - from the first flight across the Atlantic Ocean, to stealth bombers, to landing on the moon. We look for people who have bold new ideas, courage and a pioneering spirit to join forces to invent the future, and have fun along the way. Our culture thrives on intellectual curiosity, cognitive diversity and bringing your whole self to work - and we have an insatiable drive to do what others think is impossible. Our employees are not only part of history, they're making history. Northrop Grumman Space Systems-Missile Defense Integration offers an excellent opportunity for a Sr Principal DevOps Engineer (26-204) to join our team of skilled and diverse professionals. Located at Schriever Space Force Base in Colorado Springs, CO, this role is essential to supporting the U.S. President, the Secretary of Defense, and combatant commanders at the strategic, regional, and operational levels. This position does not provide relocation assistance and requires on-site work with no remote options. Position Overview: The Command and Control, Battle Management, and Communications (C2BMC) program is a key component of the Missile

Head of Customer Onboarding Remote About Feanix Bio Feanix is rebuilding animal breeding from the genome up. We're a YC-backed startup using whole-genome sequencing and custom ML models to help dairy farmers make smarter breeding and herd management decisions. Our tech is genuinely novel: we can sequence a full genome from a single hair at a fraction of industry cost, our models hit ~90% accuracy prediction on traits where the industry sits at ~30%, and we're the first to crack genomic predictions on farm specific performance. That edge is showing up in the numbers. In a short time, we've grown to cover 1% of the U.S. dairy industry - 250,000+ cows - with $2M+ in ARR and a waitlist many times that size. Our investors include Initialized Capital, General Catalyst, Collab Fund, Overwater Ventures, and YC. We started with dairy because our founders grew up on dairy farms. But genetics is a core pillar of every agricultural industry, and we're just getting started. We're building this with a small, high-caliber team where everyone owns their work end to end. No layers, no passengers, no busywork - just hard problems in biology and software that nobody has solved yet, and the resources to actually solve them. If you're exceptional at what you do and you want to ship work that moves an entire industry, this is the team to do it with. About the Role We're looking for a Head of Operations to build and lead the operational backbone of Autopilot.

Senior Staff Software Engineer - Engineering Escalations Pune, Maharashtra, India You won't just join a company at Druva, you'll help shape the future of data security at the moment it matters most. We are building a modern standard with our cloud-native solutions, designed to simplify the toughest challenges in cyber resilience for our customers. As the pioneer and market leader in fully managed SaaS data protection, we help organizations secure and recover their data from ransomware, cyberattacks, and operational disruptions without the complexity, cost, or risk of legacy infrastructure. Our momentum is backed by the market: Druva was named a Leader in the 2025 Gartner® Magic Quadrant™ for Backup and Data Protection Platforms, a Leader in the 2025 IDC MarketScape for Cyber-Recovery, and a Leader & Outperformer in the 2025 GigaOm Cloud Data Protection Radar. Even better, customers validate that leadership every day through strong Gartner Peer Insights ratings, standout Net Promoter Scores (NPS), and top willingness-to-recommend results. Visit druva.com and follow us on LinkedIn , X and Facebook . As a Senior Staff Software Engineer - Escalations, you will be responsible for fixing product bugs and delivering code changes to the Production part of product reliability, resiliency, stability & sustenance for all Druva SaaS Customers. This role will require excellent communication skills as you will collaborate with Product Management, CloudOps, Development & Customer-Facing Teams to refine requirements, product architects to propose architectural changes, and other product owners to drive features for usability/supportability/quality. Key Skills: - 6 -9 years of

Quality Technician / Quality Chemist City Osceola Nutrien is a leading provider of crop inputs and services, and our business results make a positive impact on the world. Our purpose, Feeding the Future , is the reason we come to work each day. We're guided by our culture of care and our core values: We put safety first. We act with integrity. We are stronger together. We deliver with excellence. Nutrien Ag Solutions is the retail division of Nutrien , providing full-acre solutions through our network of trusted crop consultants at more than 2,000 locations in North America, South America, and Australia. For more than 150 years, we have been helping growers achieve the highest yields with the most sustainable solutions possible, offering a wide selection of products, including our proprietary brands: Loveland Products, Inc.; Proven®Seed and Dyna-Gro®Seed; as well as financial, custom application and precision ag services. Through the collective expertise of our nearly 26,000 employees, we operate a world-class network of production, distribution, and ag retail facilities We efficiently serve growers' needs and strive to provide a more profitable, sustainable, and secure future for all stakeholders. Help us raise the expectation of what an agriculture company can be and grow your career with Nutrien and Nutrien Ag Solutions. What You'll Do: Work 2nd shift 2PM - 10:30PM Monday through Friday Adhere to all Quality standard operating procedures (SOPs) and processes Perform routine QC testing on raw materials, intermediates, and

Associate Scientist I, Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an Associate